Add BrightSurf on Google Email

Vaccine boosts your immune system

Researchers have discovered a protein that can prevent chronic tissue inflammation and boost the immune system. The therapeutic vaccine has been shown to effectively treat conditions like multiple sclerosis and rheumatoid arthritis.

SourceUniversity of Copenhagen·JournalJournal of Clinical Investigation·DateDec 14, 2010

JCI online early table of contents: Dec. 13, 2010

Researchers have identified a mechanism that could explain why flu infections may help prevent asthma in children. Infection with influenza A virus protects mice from asthma by expanding NKT cells, which are immune cells that play a key role in the body's response to infection.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 13, 2010

A benefit of flu: protection from asthma?

Researchers found that influenza A virus infection in mice expanded a subset of immune cells called NKT cells, which protected against airway hyperreactivity. The study suggests treating children with therapeutics that activate NKT cells might prevent asthma development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 13, 2010

Making cancer killers

Scientists have created a novel type of immune system cell called Induced T to Natural Killer Cells (ITNK cells) that can kill cancer cells in lab tests and mouse models. These reprogrammed killer cells are more efficient at targeting tumour cells than unmodified Natural Killer cells.

JCI online early table of contents: June 1, 2010

GSK-3 inhibitors may have adverse effects on the heart, while NMDA molecules could provide nerve cell protection, highlighting the need for careful risk-benefit assessments. These findings have implications for developing new treatments for conditions such as Alzheimer's disease and diabetes.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 1, 2010

Preventing pancreatic islet loss after transplantation

Researchers have identified a potential new set of targets to improve the efficiency of pancreatic islet transplantation. The study found that treatment with an antibody targeting HMGB1 prevented early pancreatic islet loss and inhibited IFN-gamma production by NKT cells and Gr-1+CD11b+ cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 1, 2010

JCI online early table of contents: May 1, 2009

Researchers have identified a protein responsible for regulating branched-chain amino acid catabolism, which may be linked to Maple Syrup Urine Disease. Additionally, immune cells called V-alpha-24-invariant NKT cells can indirectly affect neuroblastoma growth by killing tumor-associated cells that promote its growth.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 1, 2009

Researchers identify cell group key to Lyme disease arthritis

A study published in Proceedings of the National Academy of Sciences shows that natural killer (NK) T cells play a crucial role in preventing chronic inflammatory infection and clearing Borrelia burgdorferi bacteria, which cause Lyme disease. The research demonstrates that NK T cells are central to reducing arthritis symptoms.

SourceLa Jolla Institute for Immunology·JournalProceedings of the National Academy of Sciences·DateDec 3, 2008

JCI table of contents: July 19, 2007

A study on mucins reveals their crucial role in protecting the gut from bacterial infection. In contrast, lupus research identifies shared signaling networks active in B cells from genetically distinct mouse models. Meanwhile, a new study shows that blocking ERK1/2 activation can prevent congenital heart defects in mice with Noonan syn...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 19, 2007

JCI table of contents: August 17, 2006

Researchers discovered that phosphatase and tensin homolog (PTEN) regulates the proliferative capabilities of naturally occurring CD4+CD25+ Tregs but not their suppressive function. This finding provides a potential solution to harnessing the therapeutic potential of Tregs in autoimmune diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 17, 2006

A new view of asthma's cause

A recent study published in PNAS found that at least two-thirds of asthma patients' pulmonary T cells are actually NKT cells, not conventional Th2 cells. This discovery may lead to the development of new treatments targeting NKT cells.

SourceBoston Children's Hospital·JournalNew England Journal of Medicine·DateMar 15, 2006

JCI table of contents, December 1 2004

Researchers at Columbia University have discovered a new treatment that improves memory in mice with Alzheimer's disease. The phosphodiesterase inhibitor rolipram was found to modify gene expression and make brain synapses more resistant to beta-amyloid accumulation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2004

A pathway to blocking autoimmunity

The study found that increasing PPAR-gamma activity in dendritic cells can activate NKT cells specifically, which may slow down the process of type 1 diabetes. Researchers believe that modulating CD1d expression and NKT cell activation could provide insight into how to combat autoimmunity.

SourceHoward Hughes Medical Institute·JournalImmunity·DateJul 20, 2004

Linking the immune system with lipid metabolism

Scientists have discovered a key role for lipid metabolism in the regulation of the immune system. The study reveals that natural killer T cells can recognize lipids on the surface of bacteria, triggering an immune response. By understanding this process, researchers hope to develop new treatments for autoimmune diseases and cancer.

SourceScripps Research Institute·JournalScience·DateDec 18, 2003

UT Southwestern researchers find immune system stages for eliminating viral infections, cancer cells

Researchers at UT Southwestern Medical Center have partially uncovered the stages in the elimination of viral infections and cancer cells by the human immune system. The study found that natural killer cells and cytotoxic T cells use different mechanisms to kill target cells, with significant differences in their roles and receptor usage.

SourceUT Southwestern Medical Center·JournalProceedings of the National Academy of Sciences·DateJun 9, 2003